Ocuphire Pharma, Inc.Ocuphire Pharma, Inc.Ocuphire Pharma, Inc.

Ocuphire Pharma, Inc.

No trades
See on Supercharts
Market capitalization
‪41.44 M‬USD
−0.46USD
‪−9.99 M‬USD
‪19.05 M‬USD
‪22.95 M‬
Beta (1Y)
0.64

About Ocuphire Pharma, Inc.

CEO
George Magrath
Headquarters
Farmington Hills
Employees (FY)
14
Founded
2018
ISIN
US67577R1023
FIGI
BBG000BT34Q3
Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of OCUP is 1.66 USD — it has decreased by 0.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Ocuphire Pharma, Inc. stocks are traded under the ticker OCUP.
Ocuphire Pharma, Inc. is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
OCUP stock is 7.55% volatile and has beta coefficient of 0.64. Check out the list of the most volatile stocks — is Ocuphire Pharma, Inc. there?
One year price forecast for Ocuphire Pharma, Inc. has a max estimate of 22.00 USD and a min estimate of 16.00 USD.
OCUP earnings for the last quarter are 0.25 USD per share, whereas the estimation was −0.22 USD resulting in a 212.61% surprise. The estimated earnings for the next quarter are −0.05 USD per share. See more details about Ocuphire Pharma, Inc. earnings.
Ocuphire Pharma, Inc. revenue for the last quarter amounts to ‪11.94 M‬ USD despite the estimated figure of ‪3.03 M‬ USD. In the next quarter revenue is expected to reach ‪5.36 M‬ USD.
Yes, you can track Ocuphire Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
OCUP stock has fallen by 9.07% compared to the previous week, the month change is a 12.89% fall, over the last year Ocuphire Pharma, Inc. has showed a 74.54% decrease.
OCUP net income for the last quarter is ‪−4.80 M‬ USD, while the quarter before that showed ‪5.56 M‬ USD of net income which accounts for −186.23% change. Track more Ocuphire Pharma, Inc. financial stats to get the full picture.
Today Ocuphire Pharma, Inc. has the market capitalization of ‪41.44 M‬, it has decreased by 16.06% over the last week.
No, OCUP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, OCUP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Ocuphire Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.
OCUP reached its all-time high on Dec 15, 2004 with the price of 18247.30 USD, and its all-time low was 1.71 USD and was reached on Apr 12, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 14.00 employees. See our rating of the largest employees — is Ocuphire Pharma, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Ocuphire Pharma, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Ocuphire Pharma, Inc. stock shows the sell signal. See more of Ocuphire Pharma, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Ocuphire Pharma, Inc. future price: according to them, OCUP price has a max estimate of 22.00 USD and a min estimate of 16.00 USD. Read a more detailed Ocuphire Pharma, Inc. forecast: see what analysts think of Ocuphire Pharma, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Ocuphire Pharma, Inc. EBITDA is ‪−10.56 M‬ USD, and current EBITDA margin is −55.42%. See more stats in Ocuphire Pharma, Inc. financial statements.